Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

LianBio Sponsored ADR (LIANY) vs Seres Therapeutics, Inc. (MCRB)

LianBio Sponsored ADR and Seres Therapeutics, Inc. are both Biotechnology companies. LianBio Sponsored ADR and Seres Therapeutics, Inc. are of similar size ($36.0M and $34.2M). Seres Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. LianBio Sponsored ADR has the higher net margin (0.00% vs −1,192.9%) and the lower return on invested capital (−450.5% vs −277.3%). Across the 13 metrics below, LianBio Sponsored ADR leads on 10 and Seres Therapeutics, Inc. on 3.

Valuation

Metric LIANY MCRB Biotechnology median
P/E 0.02 n/m 7.88
P/S n/m 18.14 11.47
P/B 0.01 0.99 2.52
Price to free cash flow 0.03 n/m 21.16
EV/EBITDA 5.71 n/m 0.74
EV/Sales n/m 64.29 10.73
Earnings yield 4,811.17% (69.03%) (28.84%)
Free cash flow yield 3,996.57% (150.01%) (23.03%)

Profitability

Metric LIANY MCRB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (4,462.77%) 0.00%
Net margin 0.00% (1,192.94%) 0.00%
Free cash flow margin 0.00% (2,721.83%) 0.00%
Return on equity 70.96% (66.57%) (57.72%)
Return on assets 66.19% (18.31%) (49.22%)
Return on invested capital (450.47%) (277.30%) 0.00%

Growth

Metric LIANY MCRB Biotechnology median
Revenue growth (TTM) — (98.51%) 5.64%
EPS growth (last fiscal year) 75.44% 0.00% —
Revenue growth, 5-year CAGR — (53.03%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIANY MCRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.03 2.11 4.73
Net debt to EBITDA 7.41 0.51 0.96

Dividend

Metric LIANY MCRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LIANY MCRB Biotechnology median
Market cap 34.19m 35.99m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack